Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 11, 2011, Pages 1619-1627

  Marysael, Thierry ^a   Ni, Yicheng ^b   Lerut, Evelyne ^b   De Witte, Peter ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

DMXAA; Hypericin; Tumor necrosis therapy; Vascular damaging agents; ZD6126

Indexed keywords

AACIDEXAM; DEXAMETHASONE; HYPERICIN; N ACETYLCOLCHINOL PHOSPHATE; UNCLASSIFIED DRUG; VADIMEZAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; FIBROSARCOMA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; TUMOR NECROSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; MICE; MICE, INBRED C3H; NECROSIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ORGANOPHOSPHORUS COMPOUNDS; PERYLENE; TELOMERE-BINDING PROTEINS; XANTHONES;

EID: 80054760369     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1032-y     Document Type: Article

References (29)

1. 131I-labeled TNT-1 monoclonal antibody Cancer Res 49 16 4578 4585 2743341 1:CAS:528:DyaL1MXlsV2lsb8%3D (Pubitemid 19208364)
2. B Chen Y Xu T Roskams E Delaey P Agostinis JR Vandenheede P de Witte 2001 Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model Int J Cancer 93 2 275 282 10.1002/ijc.1324 11410877 10.1002/ijc.1324 1:CAS:528:DC%2BD3MXltV2mtrY%3D (Pubitemid 32574285)
3. LM Ching S Zwain BC Baguley 2004 Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice Br J Cancer 90 4 906 910 10.1038/sj.bjc.6601606 14970872 10.1038/sj.bjc.6601606 1:CAS:528:DC%2BD2cXht12iurg%3D (Pubitemid 38406605)
4. EH Cooper AJ Bedford TE Kenny 1975 Cell death in normal and malignant tissues Adv Cancer Res 21 59 120 1108613 10.1016/S0065-230X(08)60971-9 1:STN:280:DyaE287gvVOkug%3D%3D
5. AL Epstein FM Chen CR Taylor 1988 A novel method for the detection of necrotic lesions in human cancers Cancer Res 48 20 5842 5848 3048650 1:STN:280:DyaL1M%2Fgt1OnsA%3D%3D
6. H Falk J Meyer M Oberreiter 1993 A convenient semisynthetic route to hypericin Monatshefte Fur Chemie 124 3 339 341 10.1007/BF00810594 1:CAS:528:DyaK3sXltlyqtLw%3D
7. S Finotto YA Mekori DD Metcalfe 1997 Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems J Clin Invest 99 7 1721 1728 10.1172/JCI119336 9120017 10.1172/JCI119336 1:CAS:528: DyaK2sXitlanuro%3D (Pubitemid 27163824)
8. H Fonge K Vunckx H Wang Y Feng L Mortelmans J Nuyts G Bormans A Verbruggen Y Ni 2008 Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I] iodohypericin microSPECT Eur Heart J 29 2 260 269 10.1093/eurheartj/ehm588 18156139 10.1093/eurheartj/ehm588 1:CAS:528:DC%2BD1cXivVyjsrw%3D (Pubitemid 351164878)
9. 131I]-chTNT-1/B mAB for treatment of high-grade adult gliomas Expert Opin Biol Ther 11 6 799 806 10.1517/14712598.2011.579097 21521146 10.1517/14712598.2011.579097 1:CAS:528:DC%2BC3MXls1KhtLg%3D
10. MR Horsman R Murata 2003 Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response Int J Radiat Oncol Biol Phys 57 4 1047 1055 10.1016/S0360-3016(03)00769-7 14575836 10.1016/S0360-3016(03)00769-7 1:CAS:528:DC%2BD3sXot12jtbk%3D (Pubitemid 37324123)
11. MR Horsman DW Siemann 2006 Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies Cancer Res 66 24 11520 11539 10.1158/0008-5472.CAN-06-2848 17178843 10.1158/0008-5472.CAN-06-2848 1:CAS:528:DC%2BD28XhtlagurrP (Pubitemid 46094158)
12. M Jain G Venkatraman SK Batra 2007 Optimization of radio immunotherapy of solid tumors: biological impediments and their modulation Clin Cancer Res 13 5 1374 1382 1078-0432.CCR-06-2436 17309914 10.1158/1078-0432.CCR-06-2436 1:CAS:528:DC%2BD2sXitlSjtr4%3D (Pubitemid 46450425)
13. C Kanthou GM Tozer 2009 Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies Int J Exp Pathol 90 3 284 294 10.1111/j.1365-2613.2009.00651.x 19563611 10.1111/j.1365-2613.2009.00651.x 1:CAS:528:DC%2BD1MXotV2isr4%3D
14. S Koljenovic LP Choo-Smith TC Bakker Schut JM Kros HJ van den Berge GJ Puppels 2002 Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy Lab Invest 82 10 1265 1277 12379761 1:CAS:528:DC%2BD38Xns1Cls78%3D (Pubitemid 35191530)
15. J Li Z Sun J Zhang H Shao M Miranda Cona H Wang T Marysael F Chen K Prinsen L Zhou D Huang J Nuyts J Yu B Meng G Bormans Z Fang P de Witte Y Li A Verbruggen X Wang L Mortelmans K Xu G Marchal Y Ni 2011 A dual-targeting anticancer approach: soil and seed principle Radiology 260 799 807 radiol.11102120 21712473 10.1148/radiol.11102120
16. MJ McKeage BC Baguley 2010 Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer Cancer 116 8 1859 1871 10.1002/cncr.24975 20166210 10.1002/cncr.24975 1:CAS:528:DC%2BC3cXlvVGlsbk%3D
17. TA Miller FW Schaefer III 2007 Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production Vet Parasitol 149 3-4 147 157 10.1016/j.vetpar.2007.08. 017 17904293 10.1016/j.vetpar.2007.08.017 1:CAS:528:DC%2BD2sXhtFeku7rO (Pubitemid 47498748)
18. Y Miyachi 2000 Pharmacologic modulation of neutrophil functions Clin Dermatol 18 3 369 373 10856669 10.1016/S0738-081X(99)00128-5 1:STN:280:DC%2BD3czhsFygug%3D%3D (Pubitemid 30336516)
19. Y Ni G Bormans F Chen A Verbruggen G Marchal 2005 Necrosis avid contrast agents: functional similarity versus structural diversity Invest Radiol 40 8 526 535 16024991 10.1097/01.rli.0000171811.48991.5a 1:CAS:528:DC%2BD2MXmt1emsb4%3D (Pubitemid 41040690)
20. Y Ni D Huyghe K Verbeke PA de Witte J Nuyts L Mortelmans F Chen G Marchal AM Verbruggen GM Bormans 2006 First preclinical evaluation of mono-[123I] iodohypericin as a necrosis-avid tracer agent Eur J Nucl Med Mol Imaging 33 5 595 601 10.1007/s00259-005-0013-2 16450141 10.1007/s00259-005-0013-2 1:CAS:528:DC%2BD28XktFSqsLs%3D
21. S Song C Xiong M Zhou W Lu Q Huang G Ku J Zhao LG Flores Jr Y Ni C Li 2011 Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin J Nucl Med 52 5 792 799 jnumed.110.086116 21498539 10.2967/jnumed.110.086116 1:CAS:528:DC%2BC3MXnsleltbo%3D
22. GM Tozer C Kanthou BC Baguley 2005 Disrupting tumour blood vessels Nat Rev Cancer 5 6 423 435 10.1038/nrc1628 15928673 10.1038/nrc1628 1:CAS:528:DC%2BD2MXks1Gmsr0%3D (Pubitemid 40791485)
23. M Van de Putte T Roskams JR Vandenheede P Agostinis PA de Witte 2005 Elucidation of the tumoritropic principle of hypericin Br J Cancer 92 8 1406 1413 10.1038/sj.bjc.6602512 15812555 10.1038/sj.bjc.6602512 (Pubitemid 40705007)
24. M Van de Putte Y Ni PA De Witte 2008 Exploration of the mechanism underlying the tumor necrosis avidity of hypericin Oncol Rep 19 4 921 926 18357376 (Pubitemid 351802660)
25. M Van de Putte H Wang F Chen PA de Witte Y Ni 2008 Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model Acad Radiol 15 1 107 113 10.1016/j.acra.2007.08.008 18078913 10.1016/j.acra.2007.08.008 (Pubitemid 350217024)
26. M Van de Putte H Wang F Chen PA De Witte Y Ni 2008 Hypericin as a marker for determination of tissue viability after radiofrequency ablation in a murine liver tumor model Oncol Rep 19 4 927 932 18357377 (Pubitemid 351802661)
27. H Wang C Cao B Li S Chen J Yin J Shi D Ye Q Tao P Hu A Epstein D Ju 2008 Immunogenicity of iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients Cancer Immunol Immunother 57 5 677 684 10.1007/s00262-007-0406-0 17934732 10.1007/s00262-007-0406-0 1:CAS:528:DC%2BD1cXitlKjtr8%3D (Pubitemid 351641029)
28. LC Wang L Thomsen R Sutherland CB Reddy SM Tijono CJ Chen CE Angel PR Dunbar LM Ching 2009 Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404) Neoplasia 11 8 793 803 19649209 1:CAS:528:DC%2BD1MXoslKiurs%3D
29. H Wang J Li F Chen F De Keyzer J Yu Y Feng J Nuyts G Marchal Y Ni 2010 Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours Eur Radiol 20 8 2013 2026 10.1007/s00330-010-1743-5 20182730 10.1007/s00330-010-1743-5